Close Menu

NEW YORK – Digital pathology company Proscia announced on Tuesday it has raised $23 million in a Series B funding round.

The Philadelphia-based firm said that the financing will go toward accelerating its commercial expansion and ramping up its global sales, marketing, and support teams. Proscia also plans on expanding its data assets and AI application portfolio, and the financing will help the firm progress its regulatory strategy to obtain approval from the US Food and Drug Administration for its products.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.